
Paul Ogongo
@JaTcells
Followers
431
Following
3K
Media
12
Statuses
371
Human immunity. Infectious diseases. T-cells. Mycobacterium tuberculosis. Helen Hay Whitney Foundation Fellow.
Joined February 2015
RT @immunoafrica_: The fourth episode in our #TBImmunologySeries ft. @docjauro, a veterinarian & postdoc at @PittTweet, where he studies #T….
0
4
0
RT @NatRevImmunol: Finding and filling the knowledge gaps in mechanisms of T cell-mediated TB immunity to inform vaccine design https://t.c….
0
33
0
It was my pleasure to be interviewed by @immunoafrica_ for this episode of Immunology to TB. Here I share my journey as a scientist and our contributions to TB vaccine development.
2
4
17
RT @biorxiv_immuno: Mycobacterium tuberculosis suppresses protective Th17 responses during infection through multiple mechanisms https://t.….
0
2
0
Positive and uplifting progress. Congratulations @Thumbi_Ndungu and entire study team and participants.
Researchers at UKZN say an HIV cure could be on the horizon. After a two-year field test, a third of the participants managed to suppress the virus without medication for nearly a year. Professor Thumbi Ndung’u from UKZN explains. #DStv403 #eNCA
0
0
2
RT @Thumbi_Ndungu: Our combination immunotherapy clinical trial shows some promise towards ART-free HIV control. This offers hope for a HUV….
0
12
0
Significant progress in TB control efforts over recent years. The future of these achievements shouldn’t be in the balance because of uncertainty in funding modalities.
Learn about how faculty at the UCSF Center for Tuberculosis are waging the fight against #TB
0
0
5
The optimism of controlling TB is dampened by uncertainty of NIH funding. TB research has come from so far, with sparse but significant successes. It is sad to see all that likely go to the drain and plenty of careers ruined. #KeystoneTBsymposium
0
0
14
Congratulations @ProfTtweetsTB and colleagues.
Paper: MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates.
0
0
2
Check out new story with collaborators at TGEN. CRESTA, a new approach to identifying Mtb antigen specific T cells with high order of magnitude. Happy to have played a role.
Integrated, high-dimensional analysis of CD4 T cell epitope specificities and phenotypes reveals unexpected diversity in the response . #biorxiv_immuno.
1
1
13
RT @biorxiv_micrbio: Immunopeptidomics informs discovery and delivery of Mycobacterium tuberculosis MHC-II antigens for vaccine design htt….
0
5
0
Thanks @TheBrysonLab for the tweetorial as always and the cool science!.
Many of the peptides we identified are immunogenic per IEDB. We teamed up with @JaTCells to examine T cell responses to novel epitopes in a small cohort of individuals with prior Mtb exposure and found that some of these novel epitopes identified by MS are also immunogenic.
0
0
4
Happy to have made a contribution to this excellent work by @OwenKLeddy and @TheBrysonLab. A super and cool approach to identifying TB vaccine candidates.
Excited to share our latest on Mtb and antigen presentation (. Keep reading if you’re interested in host-pathogen interactions, vaccines, and human immunology! Led by @OwenKLeddy (on the postdoc market!).
1
0
11
RT @joanneflynn19: Happy to share @CellPress Immunity. CD4 T cells contribute to protection against #TB in a reinfe….
0
15
0
RT @KeystoneSymp: Attention scientists from low-and middle-income countries! Are you passionate about tackling #Tuberculosis? We want to he….
0
7
0
RT @Fredros_Inc: New study suggests that malaria infections might have protected Africans from COVID-19 deaths. Very interesting indeed!.~….
0
91
0